A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Fruquintinib (HMPL-013) in Healthy Subjects

Trial Profile

A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Fruquintinib (HMPL-013) in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Oct 2013

At a glance

  • Drugs Fruquintinib (Primary)
  • Indications Solid tumours
  • Focus Pharmacokinetics
  • Sponsors Hutchison MediPharma
  • Most Recent Events

    • 13 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top